Learn More
Medchemexpress LLC Mivavotinib monohydrochloride | 1952251-28-3 | 99.9% | 380.85 g/mol | C17H22ClFN6O | 5 MG

Supplier: Medchemexpress LLC HY100867A5MG
Mivavotinib monohydrochloride is an investigational small-molecule dual inhibitor of spleen tyrosine kinase (SYK) and fms related tyrosine kinase 3 (FLT3), supplied as a white to off-white solid for research use. The monohydrochloride salt displays low-nanomolar inhibitory activity against SYK and FLT3 and is provided with high purity for preclinical studies.
- Dual SYK/FLT3 inhibitor for preclinical research.
- High purity (99.9%).
- White to off-white solid formulation.
- Provided as a monohydrochloride salt for improved stability.
- Low-nanomolar potency against target kinases.
- Store at 4°C and protect from moisture for long-term stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.